304 related articles for article (PubMed ID: 15574144)
1. Prospective trial of intraoperative radiation treatment for breast cancer.
Joseph DJ; Bydder S; Jackson LR; Corica T; Hastrich DJ; Oliver DJ; Minchin DE; Haworth A; Saunders CM
ANZ J Surg; 2004 Dec; 74(12):1043-8. PubMed ID: 15574144
[TBL] [Abstract][Full Text] [Related]
2. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
[TBL] [Abstract][Full Text] [Related]
3. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update).
Holmes DR; Baum M; Joseph D
Am J Surg; 2007 Oct; 194(4):507-10. PubMed ID: 17826067
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
[TBL] [Abstract][Full Text] [Related]
5. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
Kraus-Tiefenbacher U; Bauer L; Kehrer T; Hermann B; Melchert F; Wenz F
Onkologie; 2006 Mar; 29(3):77-82. PubMed ID: 16514267
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
8. Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women.
Ivaldi GB; Leonardi MC; Orecchia R; Zerini D; Morra A; Galimberti V; Gatti G; Luini A; Veronesi P; Ciocca M; Sangalli C; Fodor C; Veronesi U
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):485-93. PubMed ID: 18407434
[TBL] [Abstract][Full Text] [Related]
9. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
[TBL] [Abstract][Full Text] [Related]
10. Early initiation of external beam radiotherapy (EBRT) may increase the risk of long-term toxicity in patients undergoing intraoperative radiotherapy (IORT) as a boost for breast cancer.
Wenz F; Welzel G; Keller A; Blank E; Vorodi F; Herskind C; Tomé O; Sütterlin M; Kraus-Tiefenbacher U
Breast; 2008 Dec; 17(6):617-22. PubMed ID: 18650091
[TBL] [Abstract][Full Text] [Related]
11. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
12. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.
Niehoff P; Ballardini B; Polgár C; Major T; Hammer J; Richetti A; Kovács G
Breast; 2006 Jun; 15(3):319-25. PubMed ID: 16765284
[TBL] [Abstract][Full Text] [Related]
13. Integrated breast conservation and intraoperative radiation therapy.
Orecchia R; Ivaldi GB; Leonardi MC
Breast; 2009 Oct; 18 Suppl 3():S98-102. PubMed ID: 19914553
[TBL] [Abstract][Full Text] [Related]
14. Partial breast irradiation: revolution or evolution?
Hannoun-Levi JM; Mazeron JJ; Marsiglia H; Gerard JP
Cancer Treat Rev; 2004 Nov; 30(7):599-607. PubMed ID: 15531394
[TBL] [Abstract][Full Text] [Related]
15. Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies.
Sauer R; Sautter-Bihl ML; Budach W; Feyer P; Harms W; Souchan R; Wollwiener D; Kreienberg R; Wenz F
Cancer; 2007 Sep; 110(6):1187-94. PubMed ID: 17647249
[TBL] [Abstract][Full Text] [Related]
16. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
17. [Accelerated partial breast irradiation following breast conservative surgery. A review of the literature].
Calais G
Cancer Radiother; 2003 Nov; 7 Suppl 1():124s-128s. PubMed ID: 15124554
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for late normal tissue complications following radiotherapy for breast cancer.
Lilla C; Ambrosone CB; Kropp S; Helmbold I; Schmezer P; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Chang-Claude J
Breast Cancer Res Treat; 2007 Nov; 106(1):143-50. PubMed ID: 17221151
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer.
Chang DW; te Marvelde L; Chua BH
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):73-9. PubMed ID: 24331652
[TBL] [Abstract][Full Text] [Related]
20. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region.
Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP
Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
